Synapticure

Synapticure is a telehealth company based in Chicago, Illinois, that focuses on care for neurodegenerative diseases. Founded in 2019 by ALS patient Brian Wallach and caregiver Sandra Abrevaya, Synapticure operates nationwide, providing virtual neurology and behavioral health services to patients and caregivers across all 50 states. The company offers a range of services, including virtual neurology care that connects patients with specialized neurologists for the management of conditions like ALS, Parkinson’s, and Alzheimer’s. They also provide access to clinical trials, behavioral health support, and 24/7 care coordination to assist with medical and logistical needs. Synapticure aims to improve access to expert care, particularly for underserved populations, and emphasizes affordability and timely service.

Hospital & Health Care Chicago, United States ~65 employees Private · Series A

Work at Synapticure in HR or recruiting? Claim this page

Employees
65
+4.8% in the 3 months to Jun 2025
Revenue / employee
$58.5K
Revenue ~$3.8M
Total funding
$46.1M
Last round Series A, Sep 2024
12-month attrition
2.4%
Tech: 5.6%
H1B sponsor
NA
Open jobs
5
Last 30 days

Headcount trend

Synapticure went from 27 employees in Jul 2023 to 65 in Jun 2025. Jan to Jun 2025: 11 people joined, 3 left.

Headcount data through Jun 2025

Funding rounds

Total funding$46.1M
Funding rounds2
Investors12

Org structure

Headcount by department

Other44
Operations9
Engineering6
Marketing2
Finance1
Sales1
Design1
Success1

Hiring now

Synapticure FAQ

How many employees does Synapticure have?

Synapticure has about 65 employees, up 4.8% over the 3 months to Jun 2025.

What is Synapticure's revenue per employee?

Synapticure makes about $58K in revenue per employee, based on $3.8M annual revenue and 65 employees.

How much funding has Synapticure raised?

Synapticure has raised $46.15M in total funding; its latest round was Series A in Sep 2024.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.